Digital Storytelling in Symptom Management Pediatric Oncology

NCT06436651 | Completed

• 1 other identifier: E.795978
• Study Type: interventional
• Target: 35
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this clinical study is to evaluate the effectiveness of the digital storytelling method in symptom management in children diagnosed with oncology. It will also provide information about children's experiences with Digital Storytelling and the use of the method. The main questions it aims to answer are:

• Is there a difference between the anxiety scores of children who applied the Digital Storytelling Method and those who did not?
• Is there a difference between the fatigue scores of children who applied the Digital Storytelling Method and those who did not?
• Is there a difference between the nausea scores of children who applied the Digital Storytelling Method and those who did not?
• Is there a difference between the pain scores of children who applied and did not apply the Digital Storytelling Method? Participants: Complete the first stage data forms. Visit the clinic every 7-15 days for the digital storytelling process, which consists of 4 stages. After the storytelling process is completed, have a process evaluation meeting with the researcher.

Conditions

Child, Only; Cancer; Symptoms and Signs; Narration

Keywords

child; cancer; nursing; symptom management; digital storytelling

Outcome Measures

Primary Outcomes (4)

• State-Trait Anxiety Inventory for Children

  It will be used to evaluate children's state anxiety.

  It will be used in the 1st and 6th interviews with the child (1st week-6th week).

• Visual Analogue Scale for Fatigue

  It is a single-item scale used to determine the intensity of fatigue in patients. The patient is asked to score his or her fatigue on a scale of 0-10. 0 means no fatigue, while 10 is considered a lot of fatigue.

  It will be applied in all interviews with the child (6 interviews), before and after the interview. It will be applied 12 times in 6 weeks.

• The Baxter Retching Faces Scale

  The scale is applied to children/adolescents in the 7-18 age group. There are a total of six items in the scale, ranging from no force to vomiting, and six facial expressions indicating each item. While the scale can be used by asking the child to choose the face that best suits him/her, the cartoon can also be shown and evaluated through observation. The average application time of the scale is 2 minutes and scores are given between 0-10. Using 0 as 'no nausea' and 10 as 'vomiting'

  It will be applied in all interviews with the child (6 interviews), before and after the interview. It will be applied 12 times in 6 weeks.

• Wong-Baker FACES pain rating scale (WB-FACES)

  This scale is used to diagnose pain in children aged 3-18. This scale has six faces representing increasing pain intensity from zero to five from left to right. The far left face has a smiling expression, indicating a pain-free state, while the far right face has a crying expression, corresponding to the most severe pain. Six facial expressions are scored from left to right on a scale of 0 to 10 points (0 points = very happy/no pain, 10 points = most severe pain). As the score from the scale increases, pain tolerance decreases, and as the score decreases, tolerance increases. The child is told to choose the face that best expresses his or her emotions.

  It will be applied in all interviews with the child (6 interviews), before and after the interview. It will be applied 12 times in 6 weeks.

Secondary Outcomes (1)

• SSPedi: Symptom Screening Scale in Pediatric Patients

  It will be used in the 1st and 6th interviews with the child (1st week-6th week).

Study Arms (2)

Experimental group

EXPERIMENTAL

Children's group where digital storytelling method was applied and stories were created

Other: Digital Storytelling

Control group

OTHER

Children's group where the stories of children in the initiative group will be watched

Other: Digital Storytelling

Interventions

Digital Storytelling OTHER

4 stages of digital storytelling will be implemented.

Control group; Experimental group

Eligibility Criteria

• Age: 7 Years - 18 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• years old,
• Having received at least 1 cure of treatment,
• Completed the induction phase and is in the consolidation phase,
• Children who and their parents agree to participate in the study.

You may not qualify if:

• who cannot speak Turkish,
• Having a secondary chronic disease
• Having a second disease that will affect the cognitive process,
• Children/adolescents who cannot complete the 4 stages of the digital storytelling process.
• Children/adolescents who cannot complete the 4 stages of the digital storytelling process.
• Children/adolescents who take a break of more than 3 weeks between storytelling processes.

Sponsors & Collaborators

• Kocaeli University: lead
• Gazi University: collaborator

Study Sites (1)

Kocaeli Universıty

Kocaeli, İzmit, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Neoplasms; Signs and Symptoms; Narration

Condition Hierarchy (Ancestors)

Pathological Conditions, Signs and Symptoms; Communication; Behavior

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Research Assistant

Study Record Dates

• First Submitted: March 29, 2024
• First Posted: May 31, 2024
• Study Start: January 13, 2024
• Primary Completion: July 30, 2024
• Study Completion: September 27, 2024
• Last Updated: August 26, 2025

Record last verified: 2024-06

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)